Cargando…

Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists

GABA(A) receptors are a major contributor to fast inhibitory neurotransmission in the brain. The receptors are activated upon binding the transmitter GABA or allosteric agonists including a number of GABAergic anesthetics and neurosteroids. Functional receptors can be formed by various combinations...

Descripción completa

Detalles Bibliográficos
Autores principales: Germann, Allison L., Burbridge, Ariel B., Pierce, Spencer R., Akk, Gustav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312946/
https://www.ncbi.nlm.nih.gov/pubmed/35883422
http://dx.doi.org/10.3390/biom12070868
_version_ 1784753957889900544
author Germann, Allison L.
Burbridge, Ariel B.
Pierce, Spencer R.
Akk, Gustav
author_facet Germann, Allison L.
Burbridge, Ariel B.
Pierce, Spencer R.
Akk, Gustav
author_sort Germann, Allison L.
collection PubMed
description GABA(A) receptors are a major contributor to fast inhibitory neurotransmission in the brain. The receptors are activated upon binding the transmitter GABA or allosteric agonists including a number of GABAergic anesthetics and neurosteroids. Functional receptors can be formed by various combinations of the nineteen GABA(A) subunits cloned to date. GABA(A) receptors containing the ε subunit exhibit a significant degree of constitutive activity and have been suggested to be unresponsive to allosteric agents. In this study, we have characterized the functional properties of the rat α1β2ε GABA(A) receptor. We confirm that the α1β2ε receptor exhibits a higher level of constitutive activity than typical of GABA(A) receptors and show that it is inefficaciously activated by the transmitter and the allosteric agonists propofol, pentobarbital, and allopregnanolone. Manipulations intended to alter ε subunit expression and receptor stoichiometry were largely without effect on receptor properties including sensitivity to GABA and allosteric agonists. Surprisingly, amino acid substitutions at the conserved 9’ and 6’ positions in the second transmembrane (TM2) domain in the ε subunit did not elicit the expected functional effects of increased constitutive activity and resistance to the channel blocker picrotoxin, respectively. We tested the accessibility of TM2 residues mutated to cysteine using the cysteine-modifying reagent 4-(hydroxymercuri)benzoic acid and found a unique pattern of water-accessible residues in the ε subunit.
format Online
Article
Text
id pubmed-9312946
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93129462022-07-26 Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists Germann, Allison L. Burbridge, Ariel B. Pierce, Spencer R. Akk, Gustav Biomolecules Article GABA(A) receptors are a major contributor to fast inhibitory neurotransmission in the brain. The receptors are activated upon binding the transmitter GABA or allosteric agonists including a number of GABAergic anesthetics and neurosteroids. Functional receptors can be formed by various combinations of the nineteen GABA(A) subunits cloned to date. GABA(A) receptors containing the ε subunit exhibit a significant degree of constitutive activity and have been suggested to be unresponsive to allosteric agents. In this study, we have characterized the functional properties of the rat α1β2ε GABA(A) receptor. We confirm that the α1β2ε receptor exhibits a higher level of constitutive activity than typical of GABA(A) receptors and show that it is inefficaciously activated by the transmitter and the allosteric agonists propofol, pentobarbital, and allopregnanolone. Manipulations intended to alter ε subunit expression and receptor stoichiometry were largely without effect on receptor properties including sensitivity to GABA and allosteric agonists. Surprisingly, amino acid substitutions at the conserved 9’ and 6’ positions in the second transmembrane (TM2) domain in the ε subunit did not elicit the expected functional effects of increased constitutive activity and resistance to the channel blocker picrotoxin, respectively. We tested the accessibility of TM2 residues mutated to cysteine using the cysteine-modifying reagent 4-(hydroxymercuri)benzoic acid and found a unique pattern of water-accessible residues in the ε subunit. MDPI 2022-06-21 /pmc/articles/PMC9312946/ /pubmed/35883422 http://dx.doi.org/10.3390/biom12070868 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Germann, Allison L.
Burbridge, Ariel B.
Pierce, Spencer R.
Akk, Gustav
Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists
title Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists
title_full Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists
title_fullStr Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists
title_full_unstemmed Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists
title_short Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists
title_sort activation of the rat α1β2ε gaba(a) receptor by orthosteric and allosteric agonists
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312946/
https://www.ncbi.nlm.nih.gov/pubmed/35883422
http://dx.doi.org/10.3390/biom12070868
work_keys_str_mv AT germannallisonl activationoftherata1b2egabaareceptorbyorthostericandallostericagonists
AT burbridgearielb activationoftherata1b2egabaareceptorbyorthostericandallostericagonists
AT piercespencerr activationoftherata1b2egabaareceptorbyorthostericandallostericagonists
AT akkgustav activationoftherata1b2egabaareceptorbyorthostericandallostericagonists